These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24889923)

  • 21. Genetic markers of treatment response to tumour necrosis factor-α inhibitors in the treatment of psoriasis.
    Ryan C; Kelleher J; Fagan MF; Rogers S; Collins P; Barker JN; Allen M; Hagan R; Renfro L; Kirby B
    Clin Exp Dermatol; 2014 Jun; 39(4):519-24. PubMed ID: 24758522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of association of OPRM1 and ABCB1 single-nucleotide polymorphisms to oxycodone response in postoperative pain.
    Zwisler ST; Enggaard TP; Mikkelsen S; Verstuyft C; Becquemont L; Sindrup SH; Brosen K
    J Clin Pharmacol; 2012 Feb; 52(2):234-42. PubMed ID: 21383334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenomics and the resulting impact on psoriasis therapies.
    Foulkes AC; Warren RB
    Dermatol Clin; 2015 Jan; 33(1):149-60. PubMed ID: 25412789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of interleukin-23 receptor variants with ankylosing spondylitis.
    Rahman P; Inman RD; Gladman DD; Reeve JP; Peddle L; Maksymowych WP
    Arthritis Rheum; 2008 Apr; 58(4):1020-5. PubMed ID: 18383363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetic study of ABCB1 and CYP3A5 genes during the first year following heart transplantation regarding tacrolimus or cyclosporine levels.
    Jordán de Luna C; Herrero Cervera MJ; Sánchez Lázaro I; Almenar Bonet L; Poveda Andrés JL; Aliño Pellicer SF
    Transplant Proc; 2011; 43(6):2241-3. PubMed ID: 21839244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.
    Foote CJ; Greer W; Kiberd BA; Fraser A; Lawen J; Nashan B; Belitsky P
    Transplant Proc; 2006 Nov; 38(9):2847-9. PubMed ID: 17112845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients.
    González-Lara L; Batalla A; Coto E; Gómez J; Eiris N; Santos-Juanes J; Queiro R; Coto-Segura P
    Arch Dermatol Res; 2015 Jul; 307(5):405-12. PubMed ID: 25537528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haplotype-based analysis of MDR1/ABCB1 gene polymorphisms in a Turkish population.
    Gümüş-Akay G; Rüstemoğlu A; Karadağ A; Sunguroğlu A
    DNA Cell Biol; 2010 Feb; 29(2):83-90. PubMed ID: 20025534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
    Heydendael VM; Spuls PI; Opmeer BC; de Borgie CA; Reitsma JB; Goldschmidt WF; Bossuyt PM; Bos JD; de Rie MA
    N Engl J Med; 2003 Aug; 349(7):658-65. PubMed ID: 12917302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort.
    Jeannesson E; Siest G; Bastien B; Albertini L; Aslanidis C; Schmitz G; Visvikis-Siest S
    Clin Chim Acta; 2009 May; 403(1-2):198-202. PubMed ID: 19285054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How genetic variation affects patient response and outcome to therapy for psoriasis.
    Woolf RT; Smith CH
    Expert Rev Clin Immunol; 2010 Nov; 6(6):957-66. PubMed ID: 20979559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and genotype distribution of ABCB1 gene polymorphisms among Maharashtrian population of Central India.
    Pramanik S; Surendran ST; Devi S; Krishnamurthi K; Chakrabarti T
    Xenobiotica; 2014 Jun; 44(6):579-82. PubMed ID: 24308438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic basis of psoriasis vulgaris and its pharmacogenetic potential.
    Ameen M
    Pharmacogenomics; 2003 May; 4(3):297-308. PubMed ID: 12718720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin.
    Campalani E; Allen MH; Fairhurst D; Young HS; Mendonca CO; Burden AD; Griffiths CE; Crook MA; Barker JN; Smith CH
    Br J Dermatol; 2006 Feb; 154(2):345-52. PubMed ID: 16433808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the CTG (-2578/-460/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis.
    Wongpiyabovorn J; Yooyongsatit S; Ruchusatsawat K; Avihingsanon Y; Hirankarn N
    Tissue Antigens; 2008 Nov; 72(5):458-63. PubMed ID: 18937791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patients.
    Foote CJ; Greer W; Kiberd B; Fraser A; Lawen J; Nashan B; Belitsky P
    Transplantation; 2007 May; 83(10):1380-4. PubMed ID: 17519790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis.
    Hirano T; Oka K; Umezawa Y; Hirata M; Oh-i T; Koga M
    Clin Pharmacol Ther; 1998 Apr; 63(4):465-70. PubMed ID: 9585801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of psoriasis to PGLYRP and SPRR genes at PSORS4 locus on 1q shows heterogeneity between Finnish, Swedish and Irish families.
    Kainu K; Kivinen K; Zucchelli M; Suomela S; Kere J; Inerot A; Baker BS; Powles AV; Fry L; Samuelsson L; Saarialho-Kere U
    Exp Dermatol; 2009 Feb; 18(2):109-15. PubMed ID: 18643845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasis.
    Warren RB; Griffiths CE
    Br J Dermatol; 2005 Nov; 153(5):869-73. PubMed ID: 16225593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.